The programme of the 2023 EFMC International Symposium on Chemical Biology will include the following sessions:
- Chemical Immunology & Checkpoint Inhibitors
Chair: Sascha Hoogendoorn, University of Geneva, Switzerland
- Chemical Proteomics in Drug Discovery
Chair: Sebastian Essig, Bayer, Germany
- Chemically Induced Proximity
Chair: Gonçalo Bernardes, University of Cambridge, United Kingdom
- Computational Chemical Biology (LS-EuChemS Session)
Chair: Sonsoles Martin Santamaria, CIB-CSIC, Spain
- New Understanding of Post-translational Modifications
Chair: Christian Adam Olsen, University of Copenhagen, Denmark
- Protein Conformations: Beyond the Ground State
Chair: Wolfgang Jahnke, Novartis, Switzerland
- Target Engagement and Mechanism of Action Determination
Chair: Andrew Zhang, AstraZeneca, United States
- Targeting Metabolism (ICBS Session)
Chair: Zaneta Nikolovska-Coleska, University of Michigan, United States